Plaintiffs in the case, including medical marijuana patients, told the 2nd U.S. Circuit Court of Appeals that the DEA’s refusal to reschedule cannabis damaged their health and that the federal agency should remove cannabis from Schedule 1.
An earlier federal court, however, dismissed the case in 2017, asserting that the plaintiffs hadn’t yet exhausted all the administrative avenues to changing marijuana’s status. The plaintiffs appealed.
Read the full report at